GGrantIndex
Sort

78,016 grants matching breast cancer

Modeling Best Approaches for Cardiovascular Disease Prevention in Cancer Survivors

$697,894
Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA

Tamoxifen &Second Breast Cancer: Epidemiology/Pathology

$697,872
Fred Hutchinson Cancer Research Center · R01 · FY2005 · CA

Modeling Susceptibility to Radiation Therapy-induced Cardiotoxicity Using Cell Village iPSCs

$697,854
Joseph C Wu · Stanford University · R01 · FY2024 · HL

Radiation-induced translational control of gene expression

$697,852
Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Mechanisms of racial disparity in breast cancer-related lymphedema

$697,823
Babak J Mehrara · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA

Novel Comprehensive Proteome Analyses of Metastasis

$697,815
Wistar Institute · R33 · FY2002 · CA

Relationships between parity, breastfeeding and ER- breast cancer in African American women: Elucidating the biologic underpinnings at the molecular and cellular level.

$697,798
Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2019 · CA

Self-administered hypnosis treatment for the management of hot flashes in women: A randomized clinical trial

$697,722
Gary R Elkins · Baylor University · R01 · FY2019 · AT

Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancer

$697,654
Semanti Mukherjee · Sloan-Kettering Inst Can Research · R37 · FY2025 · CA

Radiomic and genomic predictors of breast cancer risk

$697,652
Weiva Sieh · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

NCI CFRBCCS INFORMATICS CENTER AT UCI

$697,639
University Of California Irvine · U01 · FY2000 · CA

Molecular mechanism of Na+ -coupled HCO3- transporters: transport of CO3= and CO2

$697,577
Walter F Boron · Case Western Reserve University · R01 · FY2021 · DK

(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer

$697,539
Anna Karolina Palucka · Jackson Laboratory · R01 · FY2017 · CA

Center for Cell-based Therapy - Cures

$697,518
Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

A NEW PERSISTENCE MECHANISM FOR DRUG-TOLERANT BREAST CANCER CELLS

$697,455
University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2020 · Defense Health Agency

A Unique Class of Reductively Activated Oncology Drugs

$697,415
Dale L Boger · Scripps Research Institute, The · R01 · FY2019 · CA

Circulating Vitamin D Levels and Risk of Breast and Colorectal Cancer: a Pooled A

$697,412
Stephanie A Smith-Warner · Harvard School Of Public Health · R01 · FY2010 · CA

Leadership, Planning, and Evaluation

$697,412
Stanton L Gerson · Case Western Reserve University · P30 · FY2020 · CA

Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells

$697,267
Ettore Appella · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity

$697,166
Sharon S Evans · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA

Genomic and Morphologic Predictor of High-Risk DCIS

$697,151
Robert B West · Stanford University · R01 · FY2018 · CA

SALSA - Study of Active Lifestyle Activation

$697,143
Eric Jessen Chow · Fred Hutchinson Cancer Center · R01 · FY2022 · CA

Heartland Cancer Research CCOP

$697,095
Alan P Lyss · Missouri Baptist Medical Center · U10 · FY2011 · CA

CCOP: Colorado Cancer Research Program

$696,877
Eduardo R Pajon · Western States Cancer Research Ncorp · U10 · FY2007 · CA

Robust and Interpretable Multi-modal AI/ML for Precision Medicine

$696,824
Tianlong Chen · Univ Of North Carolina Chapel Hill · R01 · FY2025 · EB